229 results
Page 2 of 12
SC TO-I
EX-99
dtiwb1s16cs3wf1f
20 Aug 19
Issuer tender offer statement
5:01pm
8-K
EX-10.2
l30 fwvggw9
7 Aug 19
Entry into a Material Definitive Agreement
4:45pm
SC TO-I/A
EX-99
1zapkh
6 Jun 19
Issuer tender offer statement (amended)
5:01pm
SC TO-I
EX-99
gpg sqny4vn
28 May 19
Issuer tender offer statement
5:26pm
S-8
8367nzgtzpirv65bji
3 May 19
Registration of securities for employees
5:06pm
S-8
EX-4.2
hgdlq0a3 0lj
3 May 19
Registration of securities for employees
5:06pm
8-K
EX-10.1
ydebp4y6xe5l18ghb
5 Apr 19
Adhera Therapeutics Appoints Nancy Phelan as Chief Executive Officer
9:29am
8-K
EX-10.2
k0cw9v4
5 Apr 19
Adhera Therapeutics Appoints Nancy Phelan as Chief Executive Officer
9:29am
8-K
EX-99.1
om0m4dhhn016l
7 Mar 19
Adhera Therapeutics and Alyvant Enter into Digital Co-Promotion Agreement for Prestalia
12:00am
8-K
EX-10.1
rapxl5cln 61quyct
3 Oct 18
Marina Biotech Appoints Nancy R. Phelan to the Board of Directors
8:30am
8-K
EX-10.1
qizc8
24 Sep 18
Marina Biotech Appoints Eric Teague as Chief Financial Officer
4:30pm
8-K
EX-10.1
vd03n5
20 Jun 18
Marina Biotech Appoints Robert Moscato to Chief Executive Officer
11:40am
8-K
EX-10.2
kbogaaw5mzho2agd3p
18 May 18
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.1
it8k0wlesityc2zqt
24 Nov 17
Entry into a Material Definitive Agreement
12:00am